GH Research News

Stifel Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsNov 21 08:31 ET

H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsNov 19 12:32 ET

Promising Advancements in GH Research's Clinical Trials Boost Buy Rating

TipRanksNov 19 12:06 ET

GH Research Is Maintained at Buy by Canaccord Genuity

Dow JonesNov 18 09:31 ET

GH Research Analyst Ratings

BenzingaNov 18 09:21 ET

TD Cowen Maintains GH Research(GHRS.US) With Buy Rating

Moomoo NewsNov 15 08:33 ET

JMP Securities Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39

Moomoo NewsNov 15 01:32 ET

TD Cowen Maintains GH Research(GHRS.US) With Buy Rating

Moomoo NewsNov 15 00:33 ET

JMP Securities Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39

Moomoo NewsNov 14 16:32 ET

GH Research's Promising Clinical Progress and Financial Strength Reaffirm Buy Rating With $39 Price Target

TipRanksNov 14 16:01 ET

TD Cowen Maintains GH Research(GHRS.US) With Buy Rating

Moomoo NewsSep 6 16:31 ET

H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsSep 5 09:32 ET

GH Research Analyst Ratings

BenzingaSep 4 12:22 ET

CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsSep 4 07:33 ET

JMP Securities Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39

Moomoo NewsSep 4 01:31 ET

JMP Securities Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39

Moomoo NewsSep 3 15:31 ET

Buy Rating Affirmed for GH Research Amid Anticipated Clinical Advances and Strong Leadership

TipRanksSep 3 14:47 ET

GH Research Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow JonesJul 31 08:39 ET

GH Research Analyst Ratings

BenzingaJul 31 08:29 ET

H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsJul 31 06:33 ET